OrthoMimetics secures £5 million
Article Date: Jan 01 2007OrthoMimetics, a technology spin-out from the Cambridge-MIT Institute, has secured £5 million from a consortium of investors.
The Series A funding round was led by Oxford Capital Partners and included Schroders Investment Management, Sloane Robinson Private Equity and a global investment bank.
OrthoMimetics, which specialises in medical-device technology for the repair and regeneration of bone and soft-tissue damage, will use the funds to advance the development of its first two products.
Oxford Capital Partners’ investment was led by director David Mott, who said: “We believe OrthoMimetics has the potential to make an important contribution to orthopaedic medicine and has already attracted the attention of major medical device companies.”
This story is from Growth Company Investor, the independent voice on fast-growing companies. Subscribe today for the latest AIM recommendations.
